Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Validation and clinical application of a newly developed high-concentration oxygen-delivery device with a jet nebulizer function Source: Annual Congress 2010 - COPD: management Year: 2010
Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005
Aerosol delivery characteristics from a new jet nebulizer in comparison with commercially available jet nebulizers Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
A novel submicron budesonide suspension demonstrates equivalent nebulization times compared to cyclodextrin-based solution formulations Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Effect of device and formulation on delivery of budesonide suspensions by nebulizers Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
A breath-actuated jet nebulizer (BAN) has dosimetric capability for a suspension formulation based on differing volume fill of medication as well as run time Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
Reduction of nebulization time can be achieved with a new jet nebulizer design Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006
Aerosolization of nanoparticle suspensions in ethanol using Mystic™ drug delivery technology Source: Eur Respir J 2002; 20: Suppl. 38, 541s Year: 2002
Delivery of a suspension corticosteroid formulation by small volume nebulizers: a comparative bench study Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
Electrohydrodynamic atomization of drug solutions for inhalation purposes Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001
Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation Source: Eur Respir J 2002; 20: Suppl. 38, 500s Year: 2002
A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations Source: Eur Respir J 2005; 26: Suppl. 49, 340s Year: 2005
Characterization of the performance of a new DC powered jet nebulizer system when compared with AC powered jet nebulizer systems Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Particle size and gravimetric characteristics of Clenny Aerosol, a new jet nebulizer with breath enhanced bulb Source: Eur Respir J 2001; 18: Suppl. 33, 99s Year: 2001
Delivery efficiency of electronic and jet nebulisers aerosolising a colistimethate sodium solution Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009
Investigation of Beclason efficiency in new delivery device Easi-breathe Source: Eur Respir J 2002; 20: Suppl. 38, 499s Year: 2002
A portable device capable to deliver to the airways filtered air with a submicrometric particle removal efficiency up to 90% Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease Year: 2010
Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology Source: Annual Congress 2009 - Respiratory disorders of the newborn Year: 2009
In vitro characterisation of a novel electronic nebulizer utilising a customised single dose bfs-vial to improve handling and delivery performanceSource: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009